The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase II study of weekly nanoparticle albumin-bound paclitaxel combined with cisplatin in patients with metastatic breast cancer.
Biyun Wang
No relevant relationships to disclose
Xi-Chun Hu
No relevant relationships to disclose
Si Sun
No relevant relationships to disclose
Jian Zhang
No relevant relationships to disclose
Lichen Tang
No relevant relationships to disclose
Zhong Hua Wang
No relevant relationships to disclose
Lei Ping Wang
No relevant relationships to disclose
Fangfang Lv
No relevant relationships to disclose
Qunling Zhang
No relevant relationships to disclose
Chunlei Zheng
No relevant relationships to disclose
Zhen Jia
No relevant relationships to disclose
Yunhua Lu
No relevant relationships to disclose